🇺🇸 FDA
Patent

US 7914990

Methods and products for in vitro genotyping

granted A61PA61P1/04A61P17/00

Quick answer

US patent 7914990 (Methods and products for in vitro genotyping) held by PROGENIKA BIOPHARMA, S.A. expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PROGENIKA BIOPHARMA, S.A.
Grant date
Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P1/04, A61P17/00, A61P19/02, A61P27/02